EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control

Ahmad R Sedaghat iD, David S Caradonna, Rakesh K Chandra, Christine Franzese, Stacey T Gray, Ashleigh A Halderman, Claire Hopkins iD, Edward C Kuan iD, Jivianne T Lee, Edward D McCoul iD, Erin K O'Brien, Steven D Pletcher und 6 weitere

International Forum of Allergy & Rhinology · 2023-11 · 13 (11) · 2004-2017

DOI: 10.1002/alr.23168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 12.05.2023. Verfasst von Ahmad R Sedaghat und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We identify chronic rhinosinusitis (CRS) manifestations associated with how rhinologists assess CRS control, with a focus on patient perspectives (patient‐reported CRS control).

Methods

Fifteen rhinologists were provided with real‐world data from 200 CRS patients. Participating rhinologists first classified patients’ CRS control as “controlled,” “partly controlled,” and “uncontrolled” using seven CRS manifestations reflecting European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) CRS control criteria (nasal obstruction, drainage, impaired smell, facial pain/pressure, sleep disturbance, use of systemic antibiotics/corticosteroids in past 6 months, and nasal endoscopy findings) and patient‐reported CRS control. They then classified patients’ CRS control without knowledge of patient‐reported CRS control. Interrater reliability and agreement of rhinologist‐assessed CRS control with patient‐reported CRS control and EPOS guidelines were determined.

Results

CRS control classification with and without knowledge of patient‐reported CRS control was highly consistent across rhinologists ( κ w = 0.758). Rhinologist‐assessed CRS control agreed with patient‐reported CRS control significantly better when rhinologists had knowledge of patient‐reported CRS control ( κ w = 0.736 vs. κ w = 0.554, p < 0.001). Patient‐reported CRS control, nasal obstruction, drainage, and endoscopy findings were most strongly associated with rhinologists’ assessment of CRS control. Rhinologists’ CRS control assessments weakly agreed with EPOS CRS control guidelines with ( κ w = 0.529) and without ( κ w = 0.538) patient‐reported CRS control. Rhinologists classified CRS as more controlled than EPOS guidelines in almost 50% of cases.

Conclusions

This study directly demonstrates the importance of patient‐reported CRS control as a dominant influence on rhinologists’ CRS control assessment. Knowledge of patient‐reported CRS control may better align rhinologists’ CRS control assessments and treatment decisions with patients’ perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisHumansChronic DiseaseMaleFemaleMiddle AgedAdultNasal PolypsPatient Reported Outcome MeasuresRhinosinusitis

Stichwörter der Autor:innen

EPOSchronic rhinosinusitisdisease controloutcome measurepatient-reportedrhinologist

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Otolaryngology, University of Missouri, Columbia, Missouri, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Ahmad R Sedaghat, Claire Hopkins, Edward C Kuan, Edward D McCoul, Eric W Wang, Bradford A Woodworth, William C Yao

Zitieren

APA

Sedaghat, A. R., Caradonna, D. S., Chandra, R. K., Franzese, C., Gray, S. T., Halderman, A. A., Hopkins, C., Kuan, E. C., Lee, J. T., McCoul, E. D., O'Brien, E. K., Pletcher, S. D., Pynnonen, M. A., Wang, E. W., Wise, S. K., Woodworth, B. A., Yao, W. C., & Phillips, K. M. (2023). Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control. International Forum of Allergy & Rhinology, 13(11), 2004-2017. https://doi.org/10.1002/alr.23168

Vancouver

Sedaghat AR, Caradonna DS, Chandra RK, Franzese C, Gray ST, Halderman AA, et al. Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control. International Forum of Allergy & Rhinology. 2023;13(11):2004-2017. doi:10.1002/alr.23168

BibTeX
@article{Sedaghat2023,
  author = {Sedaghat, Ahmad R and Caradonna, David S and Chandra, Rakesh K and Franzese, Christine and Gray, Stacey T and Halderman, Ashleigh A and Hopkins, Claire and Kuan, Edward C and Lee, Jivianne T and McCoul, Edward D and O'Brien, Erin K and Pletcher, Steven D and Pynnonen, Melissa A and Wang, Eric W and Wise, Sarah K and Woodworth, Bradford A and Yao, William C and Phillips, Katie M},
  title = {Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control},
  journal = {International Forum of Allergy & Rhinology},
  year = {2023},
  volume = {13},
  number = {11},
  pages = {2004--2017},
  doi = {10.1002/alr.23168}
}
Kostenlos starten →